3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
11
Fallopian Tube Neoplasms
10
Lung Neoplasms
9
Glioblastoma
8
Carcinoma, Renal Cell
7
Carcinoma, Non-Small-Cell Lung
6
Brenner Tumor
5
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Melanoma
4
Gliosarcoma
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Oligodendroglioma
3
Carcinoma
3
Astrocytoma
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Spinal Cord Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Mouth Neoplasms
2
Medulloblastoma
2
Interventions
Imatinib Mesylate
8
Specimen Handling
2
Oxaliplatin
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
temsirolimus
1
rubitecan
1
romidepsin
1
oblimersen
1
motexafin lutetium
1
guadecitabine
1
alvocidib
1
Sorafenib
1
Sirolimus
1
Semaxinib
1
Rogaratinib
1
Nivolumab
1
Leucovorin
1
Irinotecan
1
Immunoglobulin G
1
HhAntag691
1
Floxuridine
1
Erlotinib Hydrochloride
1
Doxorubicin
1
Disulfides
1
Dasatinib
1
Cetuximab
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NIH
×
Gastrointestinal Stromal Tumors
×
Disulfides
×
Clear all
NCT00324987
2017-09-14
S0502
National Cancer Institute (NCI)
Phase 3
Terminated
12 enrolled
13 charts